Anika Therapeutics Inc

ANIKNASDAQ · USD
20.33USD-0.56 (-2.67%)
7510

Anika Therapeutics Inc (ANIK) Implied Volatility Current

ANIK implied volatility is 51%. IV Rank is 8%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking ANIK implied volatility helps you identify when options premiums on Anika Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Anika Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when ANIK IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Anika Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ANIK, tracking metrics like ANIK IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ANIK signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products.

The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ANIK implied volatility sits today versus where it has been. Our scanner ranks Anika Therapeutics Inc implied volatility against its historical range, surfaces extremes in ANIK IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Anika Therapeutics Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
7.94%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)50.84%

IV Rank7.94%

Historical Volatility (30d)28.37%

IV - HV+22.47%

As of September 22, 2026

Trade options with IV on your side

Track ANIK IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial